IthaID: 2231

Names and Sequences

Functionality: Globin gene causative mutation Pathogenicity: N/A
Common Name: -α3.7 (type III) HGVS Name: NG_000006.1:g.34570_38381del
Hb Name: N/A Protein Info: N/A

Also known as:

We follow the HGVS sequence variant nomenclature and IUPAC standards.

External Links


Hemoglobinopathy Group: Thalassaemia
Hemoglobinopathy Subgroup: α-thalassaemia
Allele Phenotype:α⁺
Associated Phenotypes: Haemolytic anaemia [HP:0001878]


Chromosome: 16
Locus: NG_000006.1
Locus Location: 34570
Size: 3.812 kb
Fusion involves: α2, α1, α3.7 hybrid

Other details

Type of Mutation: Fusion
Ethnic Origin: Melanesian, Polynesian, Thai
Molecular mechanism: N/A
Inheritance: Recessive
DNA Sequence Determined: Yes

In silico pathogenicity prediction

Sequence Viewer

Note: The NCBI Sequence Viewer is not installed on the ITHANET servers but it is embedded in this page from the NCBI. Therefore, IthaGenes has no responsibility over any temporary unavailability of the service. In such a case, please Refresh the page or retry at a later stage. Otherwise, use this external link.

Publications / Origin

  1. Higgs DR, Hill AV, Bowden DK, Weatherall DJ, Clegg JB, Independent recombination events between the duplicated human alpha globin genes; implications for their concerted evolution., Nucleic Acids Res. , 12(18), 6965-77, 1984 PubMed
  2. Hill AV, Bowden DK, Trent RJ, Higgs DR, Oppenheimer SJ, Thein SL, Mickleson KN, Weatherall DJ, Clegg JB, Melanesians and Polynesians share a unique alpha-thalassemia mutation., Am. J. Hum. Genet. , 37(3), 571-80, 1985 PubMed
  3. Williams TN, Maitland K, Ganczakowski M, Peto TE, Clegg JB, Weatherall DJ, Bowden DK, Red blood cell phenotypes in the alpha + thalassaemias from early childhood to maturity., Br. J. Haematol. , 95(2), 266-72, 1996 PubMed
  4. Charoenwijitkul T, Singha K, Fucharoen G, Sanchaisuriya K, Thepphitak P, Wintachai P, Karnpean R, Fucharoen S, Molecular characteristics of α-thalassemia (3.7 kb deletion) in Southeast Asia: Molecular subtypes, haplotypic heterogeneity, multiple founder effects and laboratory diagnostics., Clin Biochem, 71(0), 31-37, 2019 PubMed
Created on 2013-10-03 11:14:48, Last reviewed on 2021-06-17 15:15:39 (Show full history)

Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaGenes are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.